Intrathecal autologous adipose-derived mesenchymal stromal cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intrathecal autologous adipose-derived mesenchymal stromal cells, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS) [Phase 2]